B. Linju Yen Regenerative Medicine Research Group, Institute of Cellular & System Medicine National Health Research Institutes (NHRI) Biography Publications Institution JoVE Articles B. Linju Yen has not added a biography. If you are B. Linju Yen and would like to personalize this page please email our Author Liaison for assistance. Publications Interleukin-25 Mediates Transcriptional Control of PD-L1 Via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses Stem Cell Reports. Sep, 2015 | Pubmed ID: 26321145 Transplantation of Human Placenta-derived Multipotent Stem Cells Reduces Ischemic Brain Injury in Adult Rats Cell Transplantation. 2015 | Pubmed ID: 25668287 Human Placenta-Derived Multipotent Cells (hPDMCs) Modulate Cardiac Injury: From Bench to Small & Large Animal Myocardial Ischemia Studies Cell Transplantation. Jan, 2015 | Pubmed ID: 25621818 Induction of Immunomodulatory Monocytes by Human Mesenchymal Stem Cell-derived Hepatocyte Growth Factor Through ERK1/2 Journal of Leukocyte Biology. Aug, 2014 | Pubmed ID: 24714552 Neocartilage Formation from Mesenchymal Stem Cells Grown in Type II Collagen-hyaluronan Composite Scaffolds Differentiation; Research in Biological Diversity. Nov-Dec, 2013 | Pubmed ID: 24462469 Multipotent Human Mesenchymal Stromal Cells Mediate Expansion of Myeloid-derived Suppressor Cells Via Hepatocyte Growth Factor/c-met and STAT3 Stem Cell Reports. 2013 | Pubmed ID: 24052949 The Role of RhoA Kinase Inhibition in Human Placenta-derived Multipotent Cells on Neural Phenotype and Cell Survival Biomaterials. Apr, 2013 | Pubmed ID: 23410680 H2O2 Accumulation Mediates Differentiation Capacity Alteration, but Not Proliferative Decline, in Senescent Human Fetal Mesenchymal Stem Cells Antioxidants & Redox Signaling. May, 2013 | Pubmed ID: 23088254 14-3-3σ Regulates β-catenin-mediated Mouse Embryonic Stem Cell Proliferation by Sequestering GSK-3β PloS One. 2012 | Pubmed ID: 22768254 Current Applications of Human Pluripotent Stem Cells: Possibilities and Challenges Cell Transplantation. 2012 | Pubmed ID: 22449556 Immunomodulatory Properties of Human Adult and Fetal Multipotent Mesenchymal Stem Cells Journal of Biomedical Science. 2011 | Pubmed ID: 21762539 Surface Expression of HLA-G is Involved in Mediating Immunomodulatory Effects of Placenta-derived Multipotent Cells (PDMCs) Towards Natural Killer Lymphocytes Cell Transplantation. 2011 | Pubmed ID: 21669042 Endogenous KLF4 Expression in Human Fetal Endothelial Cells Allows for Reprogramming to Pluripotency with Just OCT3/4 and SOX2--brief Report Arteriosclerosis, Thrombosis, and Vascular Biology. Oct, 2010 | Pubmed ID: 20689077 Upregulation of SOX9 in Lung Adenocarcinoma and Its Involvement in the Regulation of Cell Growth and Tumorigenicity Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2010 | Pubmed ID: 20651055 Brief Report--human Embryonic Stem Cell-derived Mesenchymal Progenitors Possess Strong Immunosuppressive Effects Toward Natural Killer Cells As Well As T Lymphocytes Stem Cells (Dayton, Ohio). Feb, 2009 | Pubmed ID: 18988708 Placenta-derived Multipotent Cells Differentiate into Neuronal and Glial Cells in Vitro Tissue Engineering. Part A. Jan, 2008 | Pubmed ID: 18333820 Multilineage Differentiation and Characterization of the Human Fetal Osteoblastic 1.19 Cell Line: a Possible in Vitro Model of Human Mesenchymal Progenitors Stem Cells (Dayton, Ohio). Jan, 2007 | Pubmed ID: 17204605 Placenta-derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon-gamma Stem Cells (Dayton, Ohio). Nov, 2006 | Pubmed ID: 17071860 Increased High Sensitivity C-reactive Protein and Neutrophil Count Are Related to Increased Standard Cardiovascular Risk Factors in Healthy Chinese Men International Journal of Cardiology. Jun, 2006 | Pubmed ID: 16305810 Isolation of Multipotent Cells from Human Term Placenta Stem Cells (Dayton, Ohio). 2005 | Pubmed ID: 15625118 Оценка иммуномодулирующими свойствами человеческой мезенхимальных стволовых клеток (МСК) Pei-Ju Hsu1, Ko-Jiunn Liu2, Ying-Yin Chao1, Huey-Kang Sytwu3, B. Linju Yen1 1Regenerative Medicine Research Group, Institute of Cellular & System Medicine, National Health Research Institutes (NHRI), 2National Institute of Cancer Research, National Health Research Institutes (NHRI), 3Institute of Microbiology & Immunology, National Defense Medical Center JoVE 53265 Immunologia e infezioni
Оценка иммуномодулирующими свойствами человеческой мезенхимальных стволовых клеток (МСК) Pei-Ju Hsu1, Ko-Jiunn Liu2, Ying-Yin Chao1, Huey-Kang Sytwu3, B. Linju Yen1 1Regenerative Medicine Research Group, Institute of Cellular & System Medicine, National Health Research Institutes (NHRI), 2National Institute of Cancer Research, National Health Research Institutes (NHRI), 3Institute of Microbiology & Immunology, National Defense Medical Center JoVE 53265 Immunologia e infezioni